Norge - norsk - Statens legemiddelverk

pharmaprim ab - alendronatnatriumtrihydrat - brusetablett - 70 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - belantamab mafodotin - multippelt myelom - antineoplastiske midler - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Norge - norsk - Statens legemiddelverk

abacus medicine a/s - goserelinacetat - implantat - 3.6 mg

Norge - norsk - Statens legemiddelverk

orifarm as - goserelinacetat - implantat - 3.6 mg

Norge - norsk - Statens legemiddelverk

paranova as - goserelinacetat - implantat - 3.6 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

almirall, s.a. - lebrikizumab - dermatitt, atopisk - andre dermatologiske preparater - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.

Norge - norsk - Statens legemiddelverk

laboratoires besins international s.a.s. - dienogest - tablett - 2 mg